ITI-007 for schizophrenia

9243814710_c193bba8da_k

Murtada Alsaif summarises a recent 4-week long phase II randomised controlled trial of ITI-007 for the treatment of schizophrenia, which contains some positive results for this novel intervention.

[read the full story...]